{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T10:17:43Z","timestamp":1772619463449,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.vaccine.2005.07.065","type":"journal-article","created":{"date-parts":[[2005,8,11]],"date-time":"2005-08-11T13:12:48Z","timestamp":1123765968000},"page":"157-170","source":"Crossref","is-referenced-by-count":40,"title":["Characterization of a peptide vaccine candidate mimicking an oligosaccharide epitope of Neisseria gonorrhoeae and resultant immune responses and function"],"prefix":"10.1016","volume":"24","author":[{"given":"Jutamas","family":"Ngampasutadol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary T.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunita","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.07.065_bib1","unstructured":"CDC. STD surveillance 2000; 2000. p. 15\u201323."},{"key":"10.1016\/j.vaccine.2005.07.065_bib2","unstructured":"WHO. Global prevalence and incidence of selected curable sexually transmitted infections overview and estimates, Geneva: World Health Organization; 2001. p. 15\u201320."},{"key":"10.1016\/j.vaccine.2005.07.065_bib3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00002030-199301000-00015","article-title":"Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study","volume":"7","author":"Laga","year":"1993","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.vaccine.2005.07.065_bib4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00007435-198810000-00006","article-title":"Trends in resistance of Neisseria gonorrhoeae to antimicrobial agents in the United States","volume":"15","author":"Whittington","year":"1988","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2005.07.065_bib5","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/infdis\/152.5.990","article-title":"Antibody\u2013antigen specificity in the immune response to infection with Neisseria gonorrhoeae","volume":"152","author":"Lammel","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.065_bib6","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1128\/IAI.43.2.706-709.1984","article-title":"Analysis of antigen specificity of the human serum immunoglobulin G immune response to complicated gonococcal infection","volume":"43","author":"Hook","year":"1984","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2005.07.065_bib7","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.4049\/jimmunol.124.5.2105","article-title":"Natural serum bactericidal activity against Neisseria gonorrhoeae isolates from disseminated, locally invasive, and uncomplicated disease","volume":"124","author":"Rice","year":"1980","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.07.065_bib8","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/infdis\/153.3.520","article-title":"Bactericidal antibody response of normal human serum to the lipooligosaccharide of Neisseria gonorrhoeae","volume":"153","author":"Apicella","year":"1986","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.065_bib9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1172\/JCI113067","article-title":"Specificity of antibodies against Neisseria gonorrhoeae that stimulate neutrophil chemotaxis","volume":"80","author":"Densen","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2005.07.065_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/infdis\/151.1.33","article-title":"Opsonophagocytosis of Neisseria gonorrhoeae: interaction of local and disseminated isolates with complement and neutrophils","volume":"151","author":"Ross","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.065_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1128\/IAI.54.1.63-69.1986","article-title":"Antigenic and physical diversity of Neisseria gonorrhoeae lipooligosaccharides","volume":"54","author":"Mandrell","year":"1986","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.065_bib12","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1128\/IAI.55.8.1792-1800.1987","article-title":"Physical heterogeneity of Neisserial lipooligosaccharides reflects oligosaccharides that differ in apparent molecular weight, chemical composition, and antigenic expression","volume":"55","author":"Griffiss","year":"1987","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.065_bib13","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/infdis\/174.6.1223","article-title":"Immunogenicity of Neisseria gonorrhoeae lipooligosaccharide epitope, 2C7, widely expressed in vivo with no immunochemical similarity to human glycosphingolopids","volume":"174","author":"Gulati","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.065_bib14","doi-asserted-by":"crossref","first-page":"36550","DOI":"10.1074\/jbc.274.51.36550","article-title":"Structural and immunochemical characterization of a Neisseria gonorrhoeae epitope defined by a monoclonal antibody 2C7; the antibody recognizes a conserved epitope on specific lipo-oligosaccharides in spite of the presence of human carbohydrate epitopes","volume":"51","author":"Yamasaki","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2005.07.065_bib15","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0161-5890(88)90116-2","article-title":"Epitope expression of gonococcal lipooligosaccharide (LOS). Importance of the lipoidal moiety for expression of an epitope that exists in the oligosaccharide moiety of LOS","volume":"25","author":"Yamasaki","year":"1988","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2005.07.065_bib16","doi-asserted-by":"crossref","first-page":"30345","DOI":"10.1016\/S0021-9258(18)43819-7","article-title":"The structure of lipooligosaccharide produced by Neisseria gonorrhoeae, strain 15253, isolated from a patient with disseminated infection: evidence for a new glycosylation pathway of gonococcal lipooligosaccharide","volume":"269","author":"Yamasaki","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2005.07.065_bib17","doi-asserted-by":"crossref","first-page":"10872","DOI":"10.1073\/pnas.95.18.10872","article-title":"Identification of the gene (lgtG) encoding the lipooligosaccharide b chain synthesizing glucosyl transferase from Neisseria gonorrhoeae","volume":"95","author":"Banerjee","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2005.07.065_bib18","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1172\/JCI111872","article-title":"Characterization of antigens from nontypable Haemophilius influenzae recognized by human bactericidal antibodies. Role of Haemophilus outer membrane proteins","volume":"75","author":"Gnehm","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2005.07.065_bib19","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature (Lond)"},{"key":"10.1016\/j.vaccine.2005.07.065_bib20","first-page":"195","article-title":"\u201cWestern blotting\u201d, electrophoretic transfer of proteins from sodium dodecyl sulfate\u2013polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A","volume":"112","author":"Burnette","year":"1981","journal-title":"Anal Bio Chem"},{"key":"10.1016\/j.vaccine.2005.07.065_bib21","series-title":"Appendix II. Buffers","first-page":"389","author":"Chase","year":"1968"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.065_bib22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.vaccine.2005.07.065_bib23","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1073\/pnas.85.15.5409","article-title":"Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system","volume":"85","author":"Tam","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2005.07.065_bib24","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1084\/jem.164.5.1735","article-title":"G antibodies directed against protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum","volume":"164","author":"Rice","year":"1986","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2005.07.065_bib25","series-title":"Methods in enzymology","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0076-6879(94)36013-8","article-title":"Complement-mediated bacterial killing assays","author":"McQuillen","year":"1994"},{"key":"10.1016\/j.vaccine.2005.07.065_bib26","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nbt0495-366","article-title":"Expression of thioredoxin random peptide libraries on Escherichia coli cell surface as functional fusions to flagellin: a system designed for exploring protein\u2013protein interactions","volume":"13","author":"Lu","year":"1995","journal-title":"Bio\/Technology"},{"issue":"12","key":"10.1016\/j.vaccine.2005.07.065_bib27","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.1073\/pnas.89.12.5398","article-title":"A family of concanavalin A-binding peptides from a hexapeptide epitope library","volume":"89","author":"Scott","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2005.07.065_bib28","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1073\/pnas.89.12.5393","article-title":"Peptide ligands for a sugar-binding protein isolated from random peptide library","volume":"89","author":"Oldenburg","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2005.07.065_bib29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0378-1119(93)90151-R","article-title":"Identification of a peptide which binds to the carbohydrate-specific monoclonal antibody B3","volume":"128","author":"Hoess","year":"1993","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2005.07.065_bib30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0022-1759(83)90220-X","article-title":"Synthetic vaccines","volume":"61","author":"Arnon","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2005.07.065_bib31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.mi.37.100183.002233","article-title":"Synthetic peptide immunogens as vaccines","volume":"37","author":"Shinnick","year":"1983","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.vaccine.2005.07.065_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/jmbi.1996.0438","article-title":"Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans","volume":"261","author":"Valadon","year":"1996","journal-title":"J Mol Biol"},{"issue":"10","key":"10.1016\/j.vaccine.2005.07.065_bib33","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1002\/eji.1830271022","article-title":"Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics","volume":"27","author":"Phalipon","year":"1997","journal-title":"Eur J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2005.07.065_bib34","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1073\/pnas.94.6.2454","article-title":"Exploring the basis of peptide\u2013carbohydrate crossreactivity: evidence for discrimination by peptides between closely related anti-carbohydrate antibodies","volume":"94","author":"Harris","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2005.07.065_bib35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4049\/jimmunol.160.1.293","article-title":"Peptides that mimic the group B streptococcal type III capsular polysaccharide antigen","volume":"160","author":"Pincus","year":"1998","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2005.07.065_bib36","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/j.1460-2075.1994.tb06540.x","article-title":"Production of an atrial natriuretic peptide variant that is specific for type A receptor","volume":"13","author":"Cunningham","year":"1994","journal-title":"EMBO J"},{"issue":"5","key":"10.1016\/j.vaccine.2005.07.065_bib37","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1006\/jmbi.1998.2137","article-title":"All-D peptides recognized by an anti-carbohydrate antibody identified from a positional scanning library","volume":"283","author":"Pinilla","year":"1998","journal-title":"J Mol Biol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.065_bib38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1574-6968.2000.tb09317.x","article-title":"Peptide mimics elicit antibody responses against the outer-membrane lipooligosaccharide of group B Neisseria meningitidis","volume":"191","author":"Charalambous","year":"2000","journal-title":"FEMS Microbiol Lett"},{"issue":"47","key":"10.1016\/j.vaccine.2005.07.065_bib39","doi-asserted-by":"crossref","first-page":"14377","DOI":"10.1021\/bi0003691","article-title":"A structure-based approach to a synthetic vaccine for HIV-1","volume":"39","author":"Cabezas","year":"2000","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.vaccine.2005.07.065_bib40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0022-1759(91)90019-C","article-title":"Generation of anti-peptide and anti-protein sera. Effect of peptide presentation on immunogenicity","volume":"137","author":"McLean","year":"1991","journal-title":"J Immunol Methods"},{"issue":"5","key":"10.1016\/j.vaccine.2005.07.065_bib41","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1399-3011.1993.tb00465.x","article-title":"Cyclic V3-loop-related HIV-1 conjugate vaccines. Synthesis, conformation and immunological properties","volume":"41","author":"Tolman","year":"1993","journal-title":"Int J Pept Protein Res"},{"issue":"2","key":"10.1016\/j.vaccine.2005.07.065_bib42","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.121.2.566","article-title":"Subclass restriction of murine anti-carbohydrate antibodies","volume":"121","author":"Perlmutter","year":"1978","journal-title":"J Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2005.07.065_bib43","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1093\/infdis\/165-Supplement_1-S49","article-title":"Thymus-independent and thymus-dependent responses to polysaccharide antigens","volume":"165","author":"Stein","year":"1992","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.065_bib44","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1567-5769(00)00037-0","article-title":"C4bp binding to porin mediates stable serum resistance of Neisseria gonorrhoeae","volume":"1","author":"Ram","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2005.07.065_bib45","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1084\/jem.188.4.671","article-title":"Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of non-sialylated Neisseria gonorrhoeae","volume":"187","author":"Ram","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2005.07.065_bib46","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00007435-200110000-00001","article-title":"Experimental gonococcal urethritis and reinfection with homologous gonococci in male volunteers","volume":"28","author":"Schmidt","year":"2001","journal-title":"Sex Transm Dis"},{"issue":"5731","key":"10.1016\/j.vaccine.2005.07.065_bib47","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/281492a0","article-title":"Complement-fixing IgG1 constitutes a new subclass of mouse IgG","volume":"281","author":"Ey","year":"1979","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.vaccine.2005.07.065_bib48","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/0161-5890(80)90139-X","article-title":"Isotypes of mouse IgG. Part I. Evidence for \u2018non-complement-fixing\u2019 IgG1 antibodies and characterization of their capacity to interfere with IgG2 sensitization of target red blood cells for lysis by complement","volume":"17","author":"Ey","year":"1980","journal-title":"Mol Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2005.07.065_bib49","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/infdis\/166.2.316","article-title":"Human vaccination with Escherichia coli J5 mutant induces cross-reactive bactericidal antibody against Neisseria gonorrhoeae lipooligosaccharide","volume":"166","author":"Dale","year":"1992","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05007413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05007413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T03:48:35Z","timestamp":1683172115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05007413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0264410X05007413"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.07.065","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}